Tehran University of Medical Sciences

Science Communicator Platform

Share By
Designing an Outer Membrane Protein (Omp-W) Based Vaccine for Immunization Against Vibrio and Salmonella: An in Silico Approach Publisher Pubmed



Tehrani SS1 ; Jahangiri A1 ; Taherianganeh M2 ; Maghsoudi H3 ; Khalili S4 ; Fana SE5, 6 ; Maniati M7 ; Amani J1
Authors

Source: Recent Patents on Biotechnology Published:2020


Abstract

Background: Cholera triggered by Vibrio cholerae remains the main reason for morbidity and mortality all over the world. In addition, salmonellosis is regarded as an infectious disease that makes it essential for the identification and detection of Salmonella. With a beta-barrel structure consisting of eight non-parallel beta strands, OmpW family is widely distributed among gram-negative bacteria. Moreover, OmpW isolated from S. typhimurium and Vibrio cholerae can be used in vaccine design. Methods: Topology prediction was determined. T-cell and B-cell epitopes were selected from exposed areas, and sequence conservancy was evaluated. The remaining loops and inaccessible residues were removed to prepare OmpW-1. High antigenicity peptides were detected to replace inappropriate residues to obtain OmpW-2. Physicochemical properties were assessed, and antigenicity, hydrophobicity, flexibility, and accessibility were compared to the native Omp-W structure. Low score areas were removed from the designed structure for preparing the OmpW-3. To construct OmpW-4, TTFrC was used as T-CD4+ cell-stimulating factor and CTB as adjuvant to the end of the C-terminal of this sequence, which can increase the antigenicity and sequence density. The sequences were re-analyzed to delete the unfavorable residues. Besides, the solubility of the mature OmpW and the designed structure were predicted while overexpressed in E. coli. Results: The designed vaccine is a stable protein that has immune cells recognizing epitopes and is considered as an antigen. The construct can be overexpressed in an E. coli. Conclusion: The multi-epitope vaccine is a suitable stimulator for the immune system and would be a candidate for experimental research. Recent patents describe numerous inven-tions related to the clinical facets of vaccine peptide against human infectious disease. © 2020 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Finding Appropriate Signal Peptides for Secretory Production of Recombinant Glucarpidase: An in Silico Method, Recent Patents on Biotechnology (2021)
2. Suitable Signal Peptides for Secretory Production of Recombinant Granulocyte Colony Stimulating Factor in Escherichia Coli, Recent Patents on Biotechnology (2020)
3. In Silico Design and Immunoinformatics Analysis of a Chimeric Vaccine Construct Based on Salmonella Pathogenesis Factors, Microbial Pathogenesis (2023)
Experts (# of related papers)
Mohammad Reza Pourmand (1)
Maryam Nasimi (1)
Other Related Docs
4. Construction of a Chimeric Flic Including Epitopes of Ompa and Ompk36 As a Multi-Epitope Vaccine Against Klebsiella Pneumonia, Health Biotechnology and Biopharma (2021)
5. Defeating a Superbug: A Breakthrough in Vaccine Design Against Multidrug-Resistant Pseudomonas Aeruginosa Using Reverse Vaccinology, PLoS ONE (2023)
6. Designing, Optimizing, and Structure Prediction of Chimeric Protein Ctb-Ipad for Expression in E.Coli, Biosciences Biotechnology Research Asia (2015)
7. Epitope-Based Immunoinformatics Study of a Novel Pilq380–706-Pila Fusion Protein From Pseudomonas Aeruginosa, Gene Reports (2019)
8. Assessment of a Poly-Epitope Candidate Vaccine Against Hepatitis B, C, and Poliovirus in Interaction With Monocyte-Derived Dendritic Cells: An Ex-Vivo Study, Human Immunology (2020)
9. Reverse Vaccinology Approach to Identify Novel and Immunogenic Targets Against Porphyromonas Gingivalis: An in Silico Study, PLoS ONE (2022)
10. In Silico Characterization of Epitopes for Vaccine Design Against Escherichia Coli Based on Heme-Utilization Protein, Journal of Applied Biotechnology Reports (2024)
11. In Silico Analyses of Extracellular Proteins of Acinetobacter Baumannii As Immunogenic Candidates, Iranian Journal of Pharmaceutical Research (2022)
12. In Silico and in Vivo Investigations of the Immunoreactivity of Klebsiella Pneumoniae Ompa Protein As a Vaccine Candidate, Iranian biomedical journal (2024)
13. Computational Design and Analysis of a Poly-Epitope Fusion Protein: A New Vaccine Candidate for Hepatitis and Poliovirus, International Journal of Peptide Research and Therapeutics (2020)
14. In Silico Design and in Vivo Evaluation of Two Multi-Epitope Vaccines Containing Build-In Adjuvant With Chitosan Nanoparticles Against Uropathogenic Escherichia Coli, International Immunopharmacology (2023)
15. In-Silico Design of a Multi-Epitope for Developing Sero-Diagnosis Detection of Sars-Cov-2 Using Spike Glycoprotein and Nucleocapsid Antigens, Network Modeling Analysis in Health Informatics and Bioinformatics (2021)
16. Evaluation of the Immunogenicity of Diphtheria Toxoid Conjugated to Salmonella Typhimurium-Derived Ops in a Mouse Model: A Potential Vaccine Candidate Against Salmonellosis, Iranian Red Crescent Medical Journal (2016)
17. Epitope-Based Immunoinformatics Study of a Novel Hla-Mntc-Sacol0723 Fusion Protein From Staphylococcus Aureus: Induction of Multi-Pattern Immune Responses, Molecular Immunology (2019)
18. Immunoinformatics Design of Multivalent Chimeric Vaccine for Modulation of the Immune System in Pseudomonas Aeruginosa Infection, Infection# Genetics and Evolution (2020)
19. Subtractive Genomic Approach Toward Introduction of Novel Immunogenic Targets Against Clostridioides Difficile: Thinking Out of the Box, Microbial Pathogenesis (2022)
20. A Dual-Type L2 11-88 Peptide From Hpv Types 16/18 Formulated in Montanide Isa 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated With High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice, Journal of Immunology Research (2018)